REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,237,000 | -89.9% | 1,146,000 | -92.4% | 0.11% | -90.4% |
| Q2 2022 | $12,253,000 | -19.7% | 15,058,000 | -7.3% | 1.16% | -13.5% |
| Q1 2022 | $15,254,000 | -16.8% | 16,238,000 | +2.1% | 1.34% | -16.1% |
| Q3 2021 | $18,336,000 | -1.2% | 15,910,000 | 0.0% | 1.60% | -3.7% |
| Q2 2021 | $18,551,000 | +5.7% | 15,910,000 | +1.7% | 1.66% | -19.7% |
| Q1 2021 | $17,558,000 | – | 15,650,000 | – | 2.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| READYSTATE ASSET MANAGEMENT LP | 17,500,000 | $21,551,250 | 2.00% |
| CSS LLC/IL | 17,325,000 | $21,353,288 | 1.41% |
| SSI INVESTMENT MANAGEMENT LLC | 7,938,000 | $9,735,966 | 0.68% |
| Boussard & Gavaudan Investment Management LLP | 5,000 | $6,146,212 | 0.58% |
| Context Capital Management, LLC | 3,249 | $4,001 | 0.34% |
| LINDEN ADVISORS LP | 20,000,000 | $24,645,586 | 0.26% |
| AVIVA PLC | 22,325,000 | $27,381,613 | 0.12% |
| DeepCurrents Investment Group LLC | 2,384,000 | $2,931,980 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 35,500,000 | $43,718 | 0.06% |
| D. E. Shaw & Co., Inc. | 34,364,000 | $42,380,365 | 0.04% |